About 7 200 reports

  • Gastrointestinal Drugs Market Characteristics
  • Gastrointestinal Drugs Market Key Mergers And Acquisitions

The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors,...

  • Pharmaceutical
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group

Gastrointestinal Drugs Global Market Report 2018 ##.

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World
  • Market Size
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Gastrointestinal disorders are common, and a number of them have a large patient population. Across the seven major markets (the US, the UK, France,...

  • Pharmaceutical
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

You can request one free hour of our analyst’s time when you purchase this market report.

  • Pharmaceutical
  • Therapy
  • World
  • Market Size

The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of block-busters.

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World

Segments Covered ##) Global Gastrointestinal Drugs market a.

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World
  • Market Size

Growing geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to market growth.

  • Pharmaceutical
  • Therapy
  • United States
  • Forecast
  • Market Size
  • Gastrointestinal disorders
  • 65.57% of the market share comes from gastrointestinal disorders

About Human Microbiome Therapeutics Microbiome Therapeutics is developing evidence-based microbiome modulators designed to shift bacterial populations and their environment in the gastrointestinal (GI) tract to better manage serious health conditions. GIT is an organ system that includes the mouth, esophagus, stomach,...

  • Pharmaceutical
  • United States
  • World
  • Enterome Bioscience SA
  • Seres Therapeutics, Inc.

Digital Therapeutics Market by Application, Central Nervous System Disease, Gastrointestinal Disorders, Respiratory Diseases, Smoking Cessation, and Others), Product, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2017 - 2025 CHAPTER ##: INTRODUCTION ##. ##.

  • Pharmaceutical
  • Therapy
  • APAC
  • Market Size
  • GASTROINTESTINAL DRUGS
  • Global Gastrointestinal Drugs Market, Segmentation By Subsegment

Pharmaceutical Drugs Global Market Opportunities And Strategies By the Drugs For Treatment: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs,...

  • Managed Care
  • Pharmaceutical
  • Respiratory Monitoring
  • World
  • Market Size
  • GASTROINTESTINAL DRUGS
  • GLOBAL GASTROINTESTINAL DRUGS MARKET, SEGMENTATION BY SUBSEGMENT

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases.Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Pharmaceutical drugs are intended for human or...

  • Managed Care
  • Pharmaceutical
  • Respiratory Monitoring
  • World
  • Market Size
  • 14.14.2 Recent Developments / Strategy / Initiatives

Gastrointestinal Cancer captured ##. ##% share of the liquid biopsy oncology market value in 2017.

  • Biopsy
  • Managed Care
  • Pharmaceutical
  • World
  • Market Size
  • Global Gastrointestinal OTC Drugs Market
  • 07. Epidemiology of Gastrointestinal Disorders

About gastrointestinal OTC drugs OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal...

  • Managed Care
  • Pharmaceutical
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.

World OTC Pharmaceutical Market Forecast 2016-2026: Recent M& A Activity and Prospects for Rx-to-OTC Switching in Cough, Cold and Allergy, Analgesics, Gastrointestinal Medicines, and Other Leading Segments ##.

  • Managed Care
  • OTC
  • Pharmaceutical
  • World
  • Market Size
  • Gastrointestinal health
  • BASF: Business segmentation by revenue 2016

About Specialty Enzymes Enzymes, also called biocatalysts, are naturally occurring or synthetic proteins that accelerate or decelerate the rate of biochemical reactions, without undergoing change themselves. They have crucial applications in many industries, including food, feed, detergent, laundry, tanning, textiles, pharmaceuticals,...

  • Pharmaceutical
  • World
  • Market Size
  • Codexis, Inc.
  • GASTROINTESTINAL TUMORS TO ACCOUNT FOR THE LARGEST SHARE OF THE
  • GASTROINTESTINAL TUMOR MODELS IS EXPECTED TO ACCOUNT FOR THE

PDX models market is projected to grow at a CAGR of 16.7% The global PDX models market is estimated to grow at a CAGR of 16.7% from 2017 to 2022, to reach USD 167.6 million. The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer...

  • Managed Care
  • Pharmaceutical
  • Charles River Laboratories International, Inc.
  • Horizon Discovery
  • WuXi AppTec Co.
  • BAYER ACQUIRED MERCK'S CONSUMER CARE BUSINESS
  • Appendix

Markets such as this one will benefit from the greater efficiencies offered by new technologies.

  • Managed Care
  • Pharmaceutical
  • World
  • Novartis AG
  • Pfizer Inc.
  • 7.4 Gastrointestinal Disorders
  • GLOBAL INFUSION PUMP MARKET BY GASTROINTESTINAL DISEASES BY REGION,

The Global market for infusion pump is growing at a steady pace. The global infusion pump market is expected to reach USD 9710.2 million by 2023 from USD 6534.2 in 2016 with a CAGR of 5% during the forecast period. Various factors that supports the growth of the market are; increased use of infusion pumps for the delivery of drugs and other...

  • Managed Care
  • Pharmaceutical
  • World
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Global gastrointestinal OTC drugs market
  • GLOBAL GASTROINTESTINAL OTC DRUGS MARKET 2015-2020 ($ BILLIONS)

About OTC Drugs OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation,...

  • Managed Care
  • Pharmaceutical
  • World
  • Pfizer Inc.
  • Sanofi S.A.
  • BY THERAPEUTIC AREA GASTROINTESTINAL
  • Small Molecule Drug Discovery Market: Revenue in USD million, Gastrointestinal, Global, 2015-2023

The global small molecule drug discovery market is expected to witness a CAGR of 6.8% during the forecast period (2018-2023). North America dominates the market due to a rise of chronic disease in that region. Rise in Demand for Small Molecule Drugs Small molecule drugs accounted for 84% of the total pharmaceutical industry revenue...

  • Managed Care
  • Pharmaceutical
  • United States
  • World
  • AstraZeneca PLC
  • 3.4.2 BARGAINING POWER OF BUYERS

Most Active Companies ## ## ## ## ## ## ## ## ##. ## ## ##. ## ## ##. ## ## ##. ## Cargill Incorporated Tate & Lyle PLC Archer Daniels Midland Company Ingredion Incorporated Roquette Merger and Acquisitions Parternership and Joint Ventures Expansions New Product La

  • Pharmaceutical
  • World
  • Cargill Inc.
  • Ingredion Incorporated
  • Tate & Lyle PLC
  • Increasing penetration addition to increasing prevalence of chronic ailments have been backing the North America pharmaceutical Retail market.
  • North America Pharmaceutical Retail Market

SUPPLIER POWER - LOW ##.

  • Managed Care
  • Pharmaceutical
  • North America
  • World
  • Market Size
  • Pharmaceutical Market - Major Players
  • Pharmaceutical Market - Major Players

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria Summary Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical R&D. Austria was ranked sixth globally in terms of healthcare spending (11.1% of GDP). In 2016, the healthcare spending increased...

  • Managed Care
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Austria

SUPPLIER POWER - LOW ##.

  • Managed Care
  • Manufacturing
  • Packaging
  • Pharmaceutical
  • Pharmaceutical Packaging
  • Gastrointestinal disorders
  • Gastrointestinal disorders

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. Today, HER2-positive breast cancer patients are living longer with their disease, thanks to established...

  • Managed Care
  • Pharmaceutical
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

The readout of one of the most watched trials of Merck & Co. '

  • Pharmaceutical
  • United States
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • B provides a breakdown of Mallinckrodt's pipeline products by therapy area. The gastrointestinal area
  • B) Pipeline by therapy area

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary The worldwide pharmaceutical market is projected to grow from approximately $1.1 trillion in 2016 to $1.5 trillion in 2021, representing a compound annual growth rate of 6.4%....

  • Pharmaceutical
  • Alexion Pharmaceuticals, Inc.
  • Daiichi Sankyo Company
  • Eisai Co., Ltd.
  • Endo International plc
  • Gastrointestinal
  • OTC

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia Summary Indonesian pharmaceutical market increased from US$3.13 Billion in 2009 to US$6.20 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of 10.3%. The market value is expected to reach US$10.11 Billion in 2021. The growth of the...

  • Managed Care
  • Pharmaceutical
  • Indonesia
  • Southeast Asia
  • Market Size
  • e - Estimated; p - Projected
  • 6.1 INTRODUCTION

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Managed Care
  • Pharmaceutical
  • Market Size
  • Arla Foods
  • Cargill Inc.
  • GLOBAL CLINICAL NUTRITION MARKET, BY DISEASE TYPE, (2018 TO 2023) (IN USD MILLION)
  • CLINICAL NUTRITION MARKET: REVENUE IN USD MILLION, BY DISEASE TYPE, GLOBAL, 2018-2023

GASTROINTESTINAL DISORDER IS ONE OF THE MOST COMMON DISORDERS IN THE AGED POPULATION, WHO REQUIRE CLINICAL NUTRITION AS SUPPLEMENT TO MAINTAIN THE BODY-ENERGY BALANCE.

  • Managed Care
  • Pharmaceutical
  • World
  • Baxter International Inc.
  • Fresenius Group